Expert���s Corner

Advertisement

Advertisement



Oct
20
Today In Oncology
ESMO 2018: About 1 in 6 Premenopausal Patients With Early Breast Cancer Do Not Adhere to Adjuvant Endocrine Therapy
ESMO 2018: Short-HER Trial Examines Abbreviated Course of Trastuzumab in Some HER2-Positive Early Breast Cancers
ESMO 2018: Pooled Analysis of Influence of Sex on Chemotherapy Efficacy and Toxicity in Esophagogastric Cancer
ESMO 2018: Variations Between European Countries in Time to Reimbursement Decisions for New Cancer Treatments Approved by the EMA
Adoptive T-Cell Therapy for Progressive Multifocal Leukoencephalopathy
View More 
;
Advertisement
Most Read Stories
Regular Aspirin Use and Reduction in Risk for Hepatocellular Carcinoma
Estradiol as Potential Treatment for Subset of Triple-Negative Breast Cancers
Epacadostat Plus Anti–PD-1 Immunotherapy in Advanced Solid Tumors
Small Study of Neoadjuvant Combination Checkpoint Blockade in High-Risk Stage III Melanoma
Duvelisib vs Ofatumumab in Relapsed or Refractory CLL/SLL
View More 
Most Viewed Videos
Angela M. Stover, PhD, on Patient-Reported Symptoms: Results From the STAR and PRO-TECT Trials
Douglas W. Blayney, MD, on Quality Care: Better, Safer, Cheaper
Reem Karmali, MD, on Lymphomas and CAR T-Cell Therapy
Shaji K. Kumar, MD, on Multiple Myeloma: Treatment Update
Fumiko Ladd Chino, MD, on Opioid-Associated Deaths in Patients With Cancer
View More 
© 2018 HSP News Service, L.L.C.
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.